Comparison Chart Galecto, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 17/05/2024 am IST			5-day change	1st Jan Change
0.63 ^USD	-0.35%		-10.01%	-12.50%

01/05	Galecto, Inc. Announces First Patient Dosed in an Investigator-Initiated Phase 2 Trial of GB1211 in Combination with Pembrolizumab	CI
29/04	Galecto, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	GALECTO, INC.	Bio Therapeutic Drugs	-0.35%	-10.01%	-12.50%	-72.90%	-	17.08M